Ithaka Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-67,756
| Closed | -$6.6M | – | 40 |
|
|
2018
Q4 | $6.6M | Sell |
67,756
-3,971
| -6% | -$387K | 1.21% | 29 |
|
|
2018
Q3 | $9.97M | Sell |
71,727
-6,695
| -9% | -$931K | 1.48% | 28 |
|
|
2018
Q2 | $9.74M | Sell |
78,422
-1,744
| -2% | -$217K | 1.51% | 28 |
|
|
2018
Q1 | $8.94M | Sell |
80,166
-1,182
| -1% | -$132K | 1.5% | 28 |
|
|
2017
Q4 | $9.73M | Sell |
81,348
-1,793
| -2% | -$214K | 1.74% | 24 |
|
|
2017
Q3 | $11.7M | Sell |
83,141
-4,369
| -5% | -$613K | 2.14% | 18 |
|
|
2017
Q2 | $10.6M | Buy |
87,510
+241
| +0.3% | +$29.3K | 1.93% | 20 |
|
|
2017
Q1 | $10.6M | Sell |
87,269
-6,157
| -7% | -$746K | 2.05% | 19 |
|
|
2016
Q4 | $11.4M | Sell |
93,426
-19,418
| -17% | -$2.38M | 2.25% | 19 |
|
|
2016
Q3 | $13.8M | Sell |
112,844
-18,974
| -14% | -$2.33M | 2.17% | 18 |
|
|
2016
Q2 | $15.4M | Sell |
131,818
-3,357
| -2% | -$392K | 2.23% | 17 |
|
|
2016
Q1 | $18.8M | Buy |
135,175
+34,002
| +34% | +$4.73M | 2.72% | 14 |
|
|
2015
Q4 | $19.3M | Buy |
101,173
+6,713
| +7% | +$1.28M | 2.58% | 16 |
|
|
2015
Q3 | $14.8M | Buy |
94,460
+13,093
| +16% | +$2.05M | 2.27% | 20 |
|
|
2015
Q2 | $14.7M | Buy |
81,367
+19,888
| +32% | +$3.6M | 2.47% | 17 |
|
|
2015
Q1 | $10.7M | Sell |
61,479
-5,751
| -9% | -$997K | 1.69% | 29 |
|
|
2014
Q4 | $12.4M | Sell |
67,230
-5,826
| -8% | -$1.08M | 1.95% | 26 |
|
|
2014
Q3 | $12.1M | Sell |
73,056
-3,235
| -4% | -$536K | 1.82% | 28 |
|
|
2014
Q2 | $11.9M | Buy |
76,291
+9,019
| +13% | +$1.41M | 1.73% | 27 |
|
|
2014
Q1 | $10.2M | Buy |
67,272
+9,817
| +17% | +$1.49M | 1.7% | 29 |
|
|
2013
Q4 | $7.64M | Buy |
57,455
+7,366
| +15% | +$979K | 1.44% | 32 |
|
|
2013
Q3 | $5.82M | Buy |
50,089
+2,806
| +6% | +$326K | 1.35% | 33 |
|
|
2013
Q2 | $4.36M | Buy |
+47,283
| New | +$4.36M | 1.28% | 35 |
|